IPILIMUMAB for Squamous cell carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 48 adverse event reports in the FDA FAERS database where IPILIMUMAB was used for Squamous cell carcinoma.

Most Reported Side Effects for IPILIMUMAB

Side Effect	Reports	%	Deaths	Hosp.
Death	3,710	10.2%	3,709	285
Malignant neoplasm progression	3,296	9.0%	1,570	1,538
Diarrhoea	2,557	7.0%	305	1,643
Off label use	2,097	5.7%	528	731
Colitis	1,988	5.4%	293	1,229
Pyrexia	1,796	4.9%	237	1,336
Rash	1,556	4.3%	162	694
Fatigue	1,447	4.0%	176	776
Intentional product use issue	1,329	3.6%	563	347
Nausea	1,169	3.2%	139	773
Decreased appetite	990	2.7%	136	665
Immune-mediated enterocolitis	988	2.7%	73	504
Hypophysitis	981	2.7%	61	515
Dyspnoea	906	2.5%	165	651
Pneumonitis	891	2.4%	220	560